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ABSTRACT
Engineered zinc finger nucleases (ZFNs) induce
DNA double-strand breaks at specific recognition
sequences and can promote efficient introduction
of desired insertions, deletions or substitutions at
or near the cut site via homology-directed repair
(HDR) with a double- and/or single-stranded
donor DNA template. However, mutagenic events
caused by error-prone non-homologous end-joining
(NHEJ)-mediated repair are introduced with equal or
higher frequency at the nuclease cleavage site.
Furthermore, unintended mutations can also result
from NHEJ-mediated repair of off-target nuclease
cleavage sites. Here, we describe a simple
and general method for converting engineered
ZFNs into zinc finger nickases (ZFNickases) by
inactivating the catalytic activity of one monomer
in a ZFN dimer. ZFNickases show robust
strand-specific nicking activity in vitro. In addition,
we demonstrate that ZFNickases can stimulate HDR
at their nicking site in human cells, albeit at a lower
frequency than by the ZFNs from which they were
derived. Finally, we find that ZFNickases appear
to induce greatly reduced levels of mutagenic
NHEJ at their target nicking site. ZFNickases
thus provide a promising means for inducing
HDR-mediated gene modifications while reducing
unwanted mutagenesis caused by error-prone
NHEJ.
INTRODUCTION
Zinc ﬁnger nucleases (ZFNs) are chimeras of engineered
zinc ﬁnger domains fused to the non-speciﬁc nuclease
domain of the restriction enzyme FokI (1). Dimers of
ZFNs generate site-speciﬁc DNA double-strand breaks
(DSBs) with each ZFN monomer cutting one DNA
strand (2). Obligate heterodimeric versions of the FokI
nuclease domain have been engineered that minimize
homodimeric interactions between ZFN monomers
within a pair (3–6).
ZFNs, as well as engineered homing endonucleases and
transcription activator-like effector nucleases (TALENs),
can be used to improve the efﬁciency of homology-
directed repair (HDR) in a variety of different organisms
and cell types (7–9). Repair of a nuclease-induced DSB
mediated by an exogenous ‘donor template’ can be
exploited to introduce sequence alterations or insertions
*To whom correspondence should be addressed. Tel: +1 617 726 9462; Fax: +1 617 726 5684; Email: jjoung@partners.org
The authors wish it to be known that, in their opinion, the ﬁrst two authors should be regarded as joint First Authors.
Present addresses:
Thomas J. Cradick, Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta,
GA, 30332, USA.
Anton P. McCaffrey, Cell Biology Department, TriLink BioTechnologies, Inc., San Diego, CA, 92121, USA.
5560–5568 Nucleic Acids Research, 2012, Vol. 40, No. 12 Published online 28 February 2012
doi:10.1093/nar/gks179
 The Author(s) 2012. Published by Oxford University Press.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/
by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.at or near the site of the break. Although nuclease-induced
HDR is highly efﬁcient, repair of a DSB can also occur by
the non-homologous end-joining (NHEJ) pathway.
NHEJ-mediated repair of nuclease-induced DSBs has
been shown to be error-prone, leading to insertion or
deletion mutations (indels) at the site of the break (10)
or the formation of chromosomal translocations (11).
NHEJ and HDR are believed to be competing pathways
(12). Thus, although HDR-mediated alterations can be
efﬁciently introduced using engineered nucleases, alleles
can also acquire NHEJ-mediated mutations [e.g.
(13,14)]. Unwanted alterations at other off-target
genomic sites can also be introduced by NHEJ-mediated
repair; e.g. two recent reports have shown that ZFNs
introduce a greater spectrum of off-target DSBs (and
therefore NHEJ-mediated mutations) than previously
appreciated (15,16).
Given the potential undesirable consequences of
introducing DSBs in living cells, we hypothesized that it
might be possible to induce DNA repair with single strand
breaks (SSBs or nicks) as a less mutagenic alternative to
DSBs. Thousands of SSBs naturally occur per day in
human cells, generally without deleterious consequences
(17). The concept of harnessing the benign nature of
nicks for stimulation of homologous recombination has
been previously suggested in the context of theoretical
models and recombination induced by RAG proteins
(18–21). In addition, homing endonucleases have been
demonstrated to stimulate HDR when converted to
nickases (22–27). However, conferring novel DNA
binding speciﬁcities to this class of enzymes without dis-
rupting catalytic activity has proven to be challenging
because the domains for DNA recognition and cleavage
are not structurally independent (8) as they are for ZFNs
and TALENs.
Here, we describe a general method for creating
site-speciﬁc zinc ﬁnger nickases (ZFNickases). To do
this, we employed obligate heterodimeric ZFNs (4) and
introduced a mutation that had previously been described
to inactivate FokI cleavage activity (D450A) (28–30) into
one monomer, thereby directing a break to only one
strand, as recently shown with the native FokI enzyme
(31). We demonstrate that ZFNickases can generate
DNA single strand breaks efﬁciently in vitro and can
also induce targeted HDR in cultured human cells with
signiﬁcantly lower rates of associated NHEJ-mediated
mutation at the nicking site. ZFNickases provide an
important additional tool for performing highly precise
genome editing with reduced levels of NHEJ-mediated
mutagenesis.
MATERIALS AND METHODS
Qualitative in vitro analysis of ZFN and ZFNickase
activities
For in vitro protein expression experiments, we con-
structed vectors derived from pMLM290 and pMLM292
[Addgene plasmids 21872 and 21873, respectively (14)].
Zinc ﬁnger domains in the ZFNs HX735, VF2468 and
VF2471 have been described previously (14) and were
cloned as XbaI/BamHI fragments into pMLM290 and
pMLM292 vectors modiﬁed to contain 3xFLAG instead
of 1xFLAG epitopes. Previously reported zinc ﬁnger
domains designed to bind the human CCR5 gene (32,33)
were assembled from overlapping oligonucleotides
generated by DNAWorks (34) and cloned into the
3xFLAG-pMLM290 and 3xFLAG-pMLM292 vectors.
The nuclease inactivating D450A mutation (numbered
relative to the native FokI enzyme) (28) was introduced
by QuikChange Lightning Site-Directed Mutagenesis
(Agilent). The protein lysates were prepared following
manufacturer’s instructions for the T7 TnT Quick
Coupled Transcription/Translation System (Promega)
using 1mg plasmid template per 50ml lysate and
incubating for 90min at 30 C.
To generate target sites for in vitro analysis, annealed
oligonucleotides with compatible overhangs were cloned
into the BsaI restriction sites of pBAC-lacZ (using oligo-
nucleotides OC152/OC153 for CCR5; Supplementary
Table S1) as described previously (35) or the BglII/SpeI
sites of pCP5 (a gift from Daniel Voytas; using
oligonucleotides OC665/OC666 for VF2468, OC667/
OC668 for VF2471 and OC671/OC672 for HX735;
Supplementary Table S1) as described previously (36).
Primers labeled with 6-carboxyﬂuorescein (6-FAM) were
used to amplify DNA fragments for cleavage assays with
the Expand High Fidelity PCR System (Roche Applied
Science). The primers OC213/OC215 were used for
pBAC-lacZ-derived targets and OC417/OC418 were used
for pCP5-derived targets (see Supplementary Table S1 for
sequences of primers).
Cleavage reactions were performed under light-
protected conditions using opaque black tubes in 100ml
volumes with 10ml protein lysate and 80ng 6-FAM-
labeled cleavage substrate in 1x NEBuffer 4 (New
England Biolabs). Reactions were incubated at 37 C for
1h, puriﬁed using a Minelute PCR Puriﬁcation kit
(Qiagen) according to the manufacturer’s instructions
with ﬁnal elution into 20ml 0.1X buffer EB, and submitted
to the DNA Core Facility at Massachusetts General
Hospital (Cambridge, MA) for denaturing capillary elec-
trophoresis with ﬂuorescent detection. Analysis of the
resulting data was performed using Peak Scanner
Software v1.0 (Applied Biosystems).
Chromosomal EGFP repair assay in U2OS cells
For the generation of the reporter cell lines used in the
chromosomal enhanced green ﬂuorescent protein (EGFP)
repair assay, the cleavage site for the HX735 ZFNs (14)
was cloned between the lacZ open reading frame (ORF)
and the 50-truncated EGFP (qGFP) gene in plasmid
pLV.LacZqGFP (37). The donor plasmid used for these
experiments harbors a 50-truncated lacZ (qlacZ) gene
followed by the corrected EGFP ORF and also lacks a
promoter (pUC. qLacZ-GFP) (38).
To generate ZFNs and ZFNickases for mammalian
expression, zinc ﬁnger domains were cloned into a
previously described dual expression plasmid in which
the cytomegalovirus (CMV) promoter drives expression
of two ZFN monomers separated by a self-cleaving T2A
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or both of the FokI subunits in this vector as needed by
subcloning or using the QuikChange Lightning
Site-Directed Mutagenesis kit (Agilent).
For the chromosomal EGFP repair assay, U2OS-based
reporter cell lines containing the LacZ-HX735-qGFP
target locus were generated by lentiviral transduction
(LV.CMV.LacZ-HX735-qGFP) with a viral dose that
rendered <1% of cells resistant to geneticin-sulfate
(0.4mg/ml), thus preferentially generating reporter cells
with a single copy target locus (37). Reporter cells,
cultured in Dulbecco’s modiﬁed Eagle’s medium
supplemented with 10% fetal bovine serum (FBS) and
1% penicillin/streptomycin (Invitrogen), were seeded at
a density of 50000 cells/well in 24-well plates. After 24h,
the transfection was performed using X-tremeGENE HP
DNA Transfection Reagent (Roche Applied Science)
following the manufacturer’s instructions. Transfection
cocktail included 150ng of ZFN or ZFNickase expression
plasmids, 600ng of donor plasmid (pUC.qLacZ-GFP)
and 100ng of a plasmid encoding for mCherry (39) to
identify transfected cells. The extent of gene targeting
was assessed after 8 days using ﬂow cytometry
(FACSCalibur; BD Biosciences) to determine the percent-
age of EGFP-positive cells in the fraction of mCherry-
positive cells. Experiments were performed at least twice
independently in duplicate.
Trafﬁc Light Reporter assay in HEK293 cells
Trafﬁc Light Reporter (TLR) experiments were performed
as described by Certo et al. (22). Brieﬂy, oligonucleo-
tides each harboring one or two ZFN or ZFNickase
target sites (oligonucleotides ams1228/ams1229 for
the VF2468 and VF2471 sites and oligonucleotides
ams1230/ams1231 for the CCR5 site) were cloned into
the SbfI and SpeI restriction sites of the TLR2.1
plasmid. Note that the VF2468 and VF2471 targets
overlap signiﬁcantly, so only one TLR reporter encom-
passing both sites was created. Cell lines were generated
by transduction of HEK293T cells with limiting amounts
of a lentivirus containing a target site of interest cloned
into the TLR, followed by selection in 1mg/ml puromycin.
The puromycin-resistant population was then bulk sorted
by ﬂuorescence-activated cell sorting (FACS) to isolate a
polyclonal population of EGFP-negative, mCherry-
negative cells. These cells were cultured in glutamine-free
Dulbecco’s modiﬁed Eagle’s medium supplemented with
2mM L-glutamine, 10% FBS and 1% penicillin/strepto-
mycin (Invitrogen). For transfections, 1 10
5 reporter
cells were plated per 24-well plate and transfected 24h
later with 0.5mg of ZFN- or ZFNickase-encoding
plasmids and 0.5mg Donor-T2A-BFP plasmid (Addgene
plasmid 31485) using Fugene6 reagent according to the
manufacturer’s protocol (Roche Applied Science). Cells
were split into a six-well plate 24h post-transfection, and
analyzed using a ﬂow cytometer (LSRII or FACSAria;
BD Biosciences) 72h post-transfection. Transfection efﬁ-
ciency was controlled for by gating on 10
3 to 10
4
BFP-positive cells prior to HDR and NHEJ analysis.
Experiments were performed independently three times.
RESULTS
In vitro enzymatic activities of ZFNs and ZFNickases
Based on recent work demonstrating that mutational
inactivation of one monomer in a FokI dimer can
convert this nuclease into a nickase (31), we reasoned
that a similar strategy might be used to convert a ZFN
dimer into a nickase. To test this possibility, we used four
previously described ZFN pairs targeted to sites in three
endogenous human genes; one to the HOXB13 gene
(HX735), two to the VEGF-A gene (VF2468 and
VF2471) and one to the CCR5 gene (CCR5) (14,32,33).
For each ZFN pair, we arbitrarily designated one of
the monomers as the ‘Left monomer’ and the other as
the ‘Right monomer’ (Supplementary Table S2) and
generated variants of each monomer harboring a previ-
ously described mutation (D450A) that inactivates the
catalytic activity of the FokI nuclease domain (28).
To test whether inactivation of one monomer in a ZFN
pair might result in generation of a zinc ﬁnger nickase
(ZFNickase), we developed a qualitative version of an
in vitro assay similar to one recently described by
Sanders et al. (31) that allowed us to assess the introduc-
tion of breaks into either strand of a double-stranded
DNA fragment. In this system, a target site for a ZFN
is positioned asymmetrically within a DNA fragment that
is ﬂuorescently labeled on the 50-ends of both DNA
strands (Figure 1). This DNA is then incubated with
different combinations of active and inactive Left/Right
monomers that have been co-expressed in vitro using a
coupled transcription/translation system (40). Following
this incubation, ﬂuorescently labeled DNA strands of
various sizes are generated depending upon whether the
top or bottom strands are cut or not cut (Figure 1). These
ﬂuorescently labeled products can be analyzed under
denaturing conditions using capillary electrophoresis,
which separates DNA molecules based on size and
enables visualization of 6-FAM-labeled DNA strands.
Using this qualitative in vitro assay, we tested the effects
of various combinations of active/inactive monomers for
the HX735, VF2468, VF2471 and CCR5 ZFNs on their
target DNA sites. As expected, with all four active
Left/active Right pairs, both strands in the target sites
were cleaved and with all inactive Left/inactive
Right pairs, no cleavage of either strand was observed
(Figure 2a–d, top and bottom panels). However, when
pairs of active/inactive monomers were tested, we
observed preferential cleavage of only one DNA strand,
the strand with which the active ZFN monomer is
expected to make its primary DNA base contacts
(Figures 2a–d, middle panels). Analysis of the electro-
pherograms in Figure 2 reveals that the cleavage positions
for all of our ZFNickases are either identical or within 1nt
of the cleavage positions of their matched parental ZFNs
(data not shown). These results demonstrate that intro-
duction of an inactivating FokI mutation into one
monomer in a ZFN obligate heterodimer pair provides a
general method for converting ZFNs into ZFNickases and
that nicking activity can be preferentially directed to
one particular strand of the DNA.
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chromosomal EGFP reporter assay
Having established the activities of ZFNickases in vitro,
we next wished to test whether these nickases, like their
nuclease counterparts, could induce HDR at their target
sites in human cells. To do this, we used a previously
described, human cell-based reporter gene assay for moni-
toring HDR (37). In this assay, a 50 truncated EGFP
reporter gene bearing a ZFN target site of interest is
chromosomally integrated using a viral-based vector
(Figure 3a). HDR with an appropriate donor construct
leads to restoration of an intact EGFP reporter gene.
Thus, the percentages of EGFP-positive cells arising
after the co-delivery of ZFNs or ZFNickases and the
donor plasmid reﬂect the abilities of ZFNs to stimulate
HDR at the target locus.
We tested ZFNs and corresponding ZFNickases
targeted to the HX735 site for their abilities to induce
HDR in the EGFP reporter assay. ZFNs targeted to the
HX735 locus were able to stimulate gene repair, inducing
EGFP expression in 0.29% of transfected cells, a statistic-
ally signiﬁcant increase relative to the 0.01% of cells that
expressed EGFP upon transfection with a catalytically
inactive ZFN (Figure 3b). Interestingly, expression of
corresponding HX735 ZFNickases designed to nick one
strand or the other restored EGFP expression in 0.14 and
0.05% of cells, although only the former increase in HDR
was statistically signiﬁcant relative to the level observed
with the catalytically inactive ZFN. Thus, these results
suggest that a ZFNickase can induce HDR in this
EGFP reporter gene assay, albeit at a lower level than
that observed with its parental ZFN.
Assessment of HDR and NHEJ induced by ZFNs and
ZFNickases in human cells
To further test the ability of ZFNickases to induce HDR
and to simultaneously assess the rate of NHEJ-mediated
mutagenesis at the same target site, we used the recently
described ‘TLR’ (22). In this assay, the reporter harbors a
nuclease target site (or sites) of interest positioned within
Figure 1. A qualitative in vitro assay to detect cleavage and nicking by ZFNs and ZFNickases. An asymmetrically positioned full ZFN target site is
placed within a DNA fragment that has been labeled on both its 50-ends with 6-FAM ﬂuorescent dye (depicted in blue). Only 6-FAM labeled strands
will be detected in the denaturing capillary electrophoresis assay. In the example shown, the ZFN target site is positioned toward the left end of the
DNA fragment. In this conﬁguration, if nicking of the top strand occurs, this results in the generation of one short and one full-length 6-FAM
labeled product. If nicking of the bottom strand occurs, this results in the generation of one medium-length and one full-length 6-FAM labeled
product. Cleavage of both strands results in the generation of short and medium-length products. Sample electropherograms are shown with
arbitrary intensity units on the y-axis and DNA strand length on the x-axis. DNA strands expected from nicking or cleavage reactions are designated
by black arrows. Note that full-length DNA strands due to incomplete enzyme reactions may be present in addition to the expected products.
Nucleic Acids Research, 2012,Vol.40, No. 12 5563a defective EGFP coding sequence that is followed
by an mCherry coding sequence joined out of frame to
the EGFP gene via a T2A peptide sequence. HDR with
an exogenously provided donor template reconstitutes
a functional EGFP coding sequence, turning cells green,
whereas NHEJ-induced indels can create frameshifts that
place the downstream mCherry protein in-frame, turning
cells red (Figure 4a). Thus, with these reporter cells, the
extent of nuclease-induced HDR and NHEJ can be moni-
tored simultaneously for a given target site using ﬂow
cytometry.
We derived polyclonal HEK293T cell lines harboring
the TLR with targets for either the VF2468 and VF2471
ZFNs [a single cell line with both overlapping targets
present, just as they occur in the endogenous locus (14)]
or the CCR5 ZFNs. For each ZFN pair, we transfected
combinations of plasmids encoding active and/or inactive
ZFN monomers together with a donor template for
correcting the EGFP gene. Flow cytometry was then
used to determine HDR and NHEJ rates by quantifying
the percentages of EGFP-positive and mCherry-positive
cells, respectively (Figure 4b–e). For all three target sites,
ZFNs tested showed robust activities, inducing high
percentages of EGFP-positive cells (indicative of HDR
events) and even higher percentages of mCherry-positive
cells (indicative of NHEJ events) in transfected cells
(Figure 4b, left column). All but one of the six
ZFNickases tested for the three target sites induced sig-
niﬁcantly higher levels of EGFP-positive cells compared
with negative controls (Figure 4b, c, d and e). The per-
centage of EGFP-positive cells for the VF2468 and CCR5
ZFNickases are 3- to 10-fold lower than what was
observed with their corresponding ZFNs (Figure 4c and
e, compare second and third white-colored columns with
the ﬁrst white-colored column), suggesting that HDR is
induced by ZFNickases but again at a lower rate than is
observed with the parental ZFNs. The activities of the
VF2471 ZFNickases were detectable but quite low
despite the high activity of the VF2471 ZFNs
(Figure 4d). However, for all three target sites, the
ZFNickases consistently induce lower percentages of
mCherry-positive cells relative to their matched ZFNs,
suggesting that fewer mutagenic NHEJ-mediated events
are occurring with the nickases compared with the nucle-
ases (Figure 4c, d and e). In addition, the ratio of
the percentage of EGFP-positive cells to the percentage
of mCherry-positive cells is higher for ﬁve of the
six ZFNickases compared with the parental ZFN
(Figure 4f, g and h). We also found, in accordance with
previous studies conducted with homing endonucleases
and nickases, that increased donor template concentra-
tions were associated with increased nuclease- and
nickase-induced HDR frequencies (Supplementary
Figure S1 and data not shown) (22,23,27). Interestingly,
(b) (a)
(d) (c)
Figure 2. Site-speciﬁc nicking of DNA in vitro by ZFNickases. Substrates labeled with 6-FAM ﬂuorescent dye harboring (a) HX735, (b) VF2468,
(c) VF2471 or (d) CCR5 binding sites were incubated with active Left/active Right (+/+), inactive Left/active Right ( /+), active Left/inactive Right
(+/ ) and inactive Left/inactive Right ( / ) ZFN monomers. Cleavage products were subjected to denaturing capillary electrophoresis. Axes are
arbitrary intensity units (y-axis) and DNA strand length (x-axis). The y-axis is differentially scaled for each plot, whereas the x-axis is scaled
uniformly for all plots. Representative electropherograms are shown, but all experiments were performed in triplicate (data not shown). Note
that the HX735, VF2468 and VF2471 targets were cloned into the pCP5 vector that results in asymmetric placement left of center within the
substrate similar to the conﬁguration depicted in Figure 1. However, the CCR5 target is cloned into pBAC-lacZ, which results in binding site
placement right of center relative to the substrate; when the top strand is cleaved in this conﬁguration, the fragment generated is longer than when
the bottom strand is cleaved.
5564 Nucleic Acids Research, 2012,Vol.40, No. 12the effect of donor template concentration appears
to be more dramatic on nickase-induced HDR than on
nuclease-induced HDR (Supplementary Figure S1 and
data not shown). These results suggest that ZFNickases
induce higher levels of HDR events relative to NHEJ
events compared with ZFNs. Our results indicate that
ZFNickases may offer the beneﬁt of signiﬁcantly
reduced NHEJ rates albeit with a reduction in HDR
activity in cells.
DISCUSSION
In this report, we describe a general and simple method
for converting ZFNs into ZFNickases. Introduction of a
previously described D450A mutation into one monomer
of a ZFN pair can generate a ZFNickase. This result
parallels recent work from Halford and colleagues in
which they used a similar approach to convert the
wild-type FokI restriction enzyme into a nickase.
Our qualitative in vitro data demonstrate that each
ZFNickase preferentially cuts one DNA strand at a
position either identical or within 1nt of the cut positions
of its matched ZFN. Furthermore, the data show that
each ZFN monomer cuts the DNA strand to which it
makes most of its DNA base contacts, providing direct
experimental support for the model of binding and
cleavage illustrated in Figure 1. Testing in two different
human cell-based reporter systems revealed that
ZFNickases can induce HDR-mediated repair, albeit at
lower levels than matched ZFNs from which they were
derived. Of the eight ZFNickases we tested (two pairs
each derived from ZFNs targeted to four different target
sites; data presented in Figures 3 and 4), six induced stat-
istically signiﬁcant levels of HDR. The levels of HDR we
observed with the ZFNickases ranged widely, from
between 2-fold and >100-fold lower than those observed
with the corresponding ZFNs from which they were
derived. However, for at least some of the ZFNickases
we tested (e.g. HX735  /+, VF2468  /+ and +/  and
CCR5  /+ and +/ ), the levels of HDR induced were
of sufﬁciently high frequency ( 0.1%) to be useful for
research applications and some potential therapeutic
strategies. Our observations that ZFNickases can induce
HDR events and that HDR efﬁciency is positively
correlated with the concentration of donor present in
cells are consistent with the ﬁndings of others using
homing endonucleases engineered to induce nicks
(22–27). However, to our knowledge, our ﬁndings are
the ﬁrst to report that nickases derived from ZFNs can
be used to induce HDR events.
Although absolute rates of HDR were lower for
ZFNickases than ZFNs in our human cell-based
reporter assays, we also observed a consistent reduction
in mutagenic NHEJ rates in the TLR assay. This reduc-
tion is not entirely surprising given that nicks are typically
repaired without causing mutations (17). However, we do
not know the origin of the residual NHEJ-mediated events
we observed with some of the ZFNickases we tested.
Possible explanations include conversion of a nick into a
DSB that may occur with replication fork collapse (see
below) or weak residual homodimerization of the active
ZFNickase monomer that may lead to cleavage at the
intended target site. Use of improved second-generation
FokI heterodimer variants (3) may reduce activity due to
the latter mechanism [we used ﬁrst-generation FokI
heterodimer variants (4) for this study].
Importantly, for ﬁve of the six ZFNickases we tested in
the TLR assay, the ratio of HDR to NHEJ events was
increased compared with the three matched ZFNs from
which they were derived. These results demonstrate
that ZFNickases can induce HDR events with relatively
lower rates of NHEJ-mediated mutations created at the
nick site. We do not currently know the mechanism of the
ZFNickase-mediated HDR or the improved HDR:NHEJ
ratios we observe. One possibility for the improved
HDR:NHEJ ratios is that a nick in the path of a DNA
replication fork may be converted to a DSB leading to
fork collapse, the repair of which would be expected
to lead to repair by either NHEJ or HDR. A potential
hypothesis for why we observe a preferential shift from
NHEJ to HDR with ZFNickases may be the more
frequent repair of nick-induced replication fork collapse
(a)
(b)
Figure 3. Assessment of ZFNickase-mediated HDR using a human
cell-based chromosomal EGFP reporter assay. (a) A schematic of the
U2OS.LacZ-HX735-qGFP reporter construct integrated in a U2OS cell
line. Note that the orientation of the binding site in the reporter is
inverted relative to the conﬁguration at the HX735 endogenous locus,
for which the Left and Right designations were originally (but
arbitrarily) assigned. (b) ZFN and ZFNickase-mediated HDR in a
U2OS EGFP reporter line. Cells were co-transfected with the donor
plasmid and plasmids encoding HX735 ZFN pairs composed of active
Left/active Right (+/+), inactive Left/active Right ( /+), active
Left/inactive Right (+/ ) and inactive Left/inactive Right ( / ) FokI
domains. The graph shows the percentage of EGFP-positive cells
8 days following transfection. Statistically signiﬁcant differences in
HDR-based gene correction relative to donor-only control (cto) are
indicated by * (P<0.05) or ** (P<0.01).
Nucleic Acids Research, 2012,Vol.40, No. 12 5565Figure 4. Assessment of ZFNickase-mediated HDR and NHEJ using a human cell-based TLR assay. (a) Schematic of the ‘TLR’ HDR-mediated
correction of the EGFP gene with a co-transfected donor template results in EGFP-positive cells. Mutagenic NHEJ events at the nuclease target site
result in mCherry-positive cells. (b) Representative ﬂow cytometry plots showing percentages of EGFP-positive and mCherry-positive cells following
transfection of TLR cell lines with plasmid encoding the indicated ZFNs and ZFNickases and the donor template. In the experiments shown, cells
have been gated for BFP expression (encoded by the plasmid harboring the donor template) to normalize for transfection efﬁciencies. (c–e) Bar
graphs showing mean percentages of EGFP-positive and mCherry-positive cells for experiments performed with the VF2468, VF2471 and CCR5
ZFNs and ZFNickases. Results were derived from three independent experiments with SEM shown. Statistically signiﬁcant differences in HDR and
mutagenic NHEJ rates relative to donor-only control ( / ) are indicated by * (P<0.05) or ** (P<0.01). (f–h) Ratios of percentage of
EGFP-positive cells to percentage of mCherry-positive cells for the VF2468, VF2471 and CCR5 ZFNs and ZFNickases using the data from
(c–e). Data used to create Figure 4c–h is available in Supplementary Table S3.
5566 Nucleic Acids Research, 2012,Vol.40, No. 12by HDR (41), in part due to the availability of repair
factors for homologous recombination during DNA
replication in S-phase (42). Interestingly, for every target
site we tested in our human cell-based assays, one
ZFNickase combination consistently outperformed the
other with respect to absolute HDR rates and, for those
assayed using the TLR assay, improved HDR:NHEJ
ratios. This reproducible difference does not appear to
be correlated with whether the nicked strand is transcribed
or not, and there were no strand cleavage preferences
discernible from the in vitro data. It is possible that
strand-dependent differences in HDR activity arise due
to different DNA-binding afﬁnities of zinc ﬁnger
domains in each monomer and how this may affect
asymmetric accessibility to the break by cellular repair
machinery. Regardless of the precise mechanism, our
results suggest that testing both potential ZFNickases
for a given target site is worthwhile to identify the most
active nickase possible.
Our work demonstrates that ZFNickases with predict-
able strand nicking activities can be easily derived from
ZFNs and that these enzymes can be used in cells to
induce HDR with improved HDR:NHEJ ratios. It will
be of interest in future experiments to test whether
ZFNickase-induced HDR rates can be further increased
by using improved FokI heterodimer frameworks and
hyperactive FokI variants (3,43). Our observation of
reduced mutagenic NHEJ events at the target nicking
site suggest that ZFNickases will also likely induce fewer
mutations at potential off-target sites elsewhere in the
genome, a prediction that can easily be tested for ZFNs
with known off-target sites (15,16). In addition,
site-speciﬁc nickases may generally be of interest for the
study of biological phenomena such as replication fork
dynamics. Our results suggest ZFNickases may provide
a means to induce HDR with reduced mutagenesis
caused by NHEJ and that additional optimization of
this platform should be an important goal for future
investigation.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online:
Supplementary Tables 1–3 and Supplementary Figure 1.
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